Local Institution - 0104

Shenyang, Liaoning 110004

1 studies enrolling now · 1 studies all time

What they study most

Metastatic Non-small Cell Lung Cancer With MTAP Deletion

Studies at this site

• A Study to Compare the Combination of Navlimetostat (BMS-986504) With Pembrolizumab and Chemotherapy Versus Placebo Plus Pembrolizumab and Chemotherapy in First-line Metastatic Non-small Cell Lung Cancer Participants With Homozygous MTAP Deletion — Recruiting now